Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Adam Eckert

SHOCKING: Why moderna shares are rising today - You Need To See This

Moderna Inc (NASDAQ:MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

SPIKEVAX, the company's mRNA Covid-19 vaccine, has now received approval from regulators in more than 70 countries. The vaccine was previously available under Emergency Use Authorization in the U.S.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.